Showing results (211-220 of 262) with videos related to

Sort By:
Pageof 27
The British Journal of Dermatology|July 1, 2014
Basal cell carcinomas in a tertiary referral centre: a systematic analysisJ Dreier, P F Cheng, I Bogdan Alleman, et al.
British Journal of Cancer|August 26, 2010
MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcomeJ C Hassel, A Sucker, L Edler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2009
Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanomaK Strobel, B Bode, R Dummer, et al.
Biomed Research International|August 21, 2019
Erratum to "Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma"A Curioni-Fontecedro, R Pitocco, N L Schoenewolf, et al.
Biomed Research International|July 11, 2015
Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal MelanomaA Curioni-Fontecedro, R Pitocco, N L Schoenewolf, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 26, 2001
Expression of TCL1 in hematologic disordersJ Roos, I Hennig, J Schwaller, et al.
Cancer|February 15, 1995
A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoringR Dummer, M E Gore, B W Hancock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2009
Small molecules and targeted therapies in distant metastatic diseaseP Hersey, L Bastholt, V Chiarion-Sileni, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatinU Keilholz, P Martus, C J A Punt, et al.
The Journal of Investigative Dermatology|February 13, 2001
Epidermal H(2)O(2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes?K U Schallreuter, J Moore, J M Wood, et al.
Pageof 27